ANGELA URHAMMER: Open Payments
NPI 1881839108 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 43 payments from 13 companies in 2025. Trend: 2023 $125 · 2024 $649 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $154 |
| Alkermes, Inc. | 12 | $143 |
| Saluda Medical Americas, Inc. | 2 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
| ABBVIE INC. | 3 | $55 |
| Medtronic, Inc. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $22 |
| Tris Pharma Inc | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: ARISTADA, UZEDY, Evoke, REXULTI, AUSTEDO XR, VRAYLAR, MINIMED 780G, CAPLYTA.
Industry payments across KY — which companies pay providers there.
